Pyrazoloisoquinoline derivative as kinase inhibitors for the treatment of various disorders
申请人:Majid Nadeem Tahir
公开号:US20050009859A1
公开(公告)日:2005-01-13
Compounds of the formula I
are suitable for producing pharmaceuticals for the prophylaxis and therapy of diseases whose course involves an increased activity of NIK.
公式I的化合物适用于制造用于预防和治疗疾病的药物,这些疾病的病程涉及NIK活性增加。
[EN] PYRAZOLOISOQUINOLINE DERIVATIVES AS KINASE INHIBITORS<br/>[FR] DERIVES DE PYRAZOLOISOQUINOLINE UTILES COMME INHIBITEURS DE KINASE
申请人:AVENTIS PHARMA INC
公开号:WO2005012301A1
公开(公告)日:2005-02-10
Novel pyrazoloisoquinoline derivatives as kinase inhibitors are disclosed which are suitable for producing pharmaceuticals for the prophylaxis and therapy of diseases whose course involves an increased activity of NIK.